000850813 001__ 850813
000850813 005__ 20210129234634.0
000850813 0247_ $$2doi$$a10.23736/S1824-4785.18.03095-9
000850813 0247_ $$2pmid$$apmid:29869488
000850813 0247_ $$2WOS$$aWOS:000445240400006
000850813 0247_ $$2altmetric$$aaltmetric:43363251
000850813 037__ $$aFZJ-2018-04584
000850813 082__ $$a570
000850813 1001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b0$$eCorresponding author
000850813 245__ $$aRadiomics derived from amino acid PET and conventional MRI in patients with high-grade gliomas
000850813 260__ $$aTorino$$bEd. Minerva Medica$$c2018
000850813 3367_ $$2DRIVER$$aarticle
000850813 3367_ $$2DataCite$$aOutput Types/Journal article
000850813 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1552310364_625
000850813 3367_ $$2BibTeX$$aARTICLE
000850813 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000850813 3367_ $$00$$2EndNote$$aJournal Article
000850813 520__ $$aRadiomics is a technique that uses high-throughput computing to extract quantitative features from tomographic medical images such as MRI and PET that usually are beyond visual perception. Importantly, the radiomics approach can be performed using neuroimages that have already been acquired during the routine follow-up of the patients allowing an additional data evaluation at low cost. In Neuro-Oncology, these features can potentially be used for differential diagnosis of newly diagnosed cerebral lesions suggestive for brain tumors or for the prediction of response to a neurooncological treatment option. Furthermore, especially in the light of the recent update of the World Health Organization classification of brain tumors, radiomics also has the potential to non-invasively assess important prognostic and predictive molecular markers such as a mutation in the isocitrate dehydrogenase gene or a 1p/19q codeletion which are not accessible by conventional visual interpretation of MRI or PET findings. This review summarizes the current status of the rapidly evolving field of radiomics with a special focus on patients with high-grade gliomas.
000850813 536__ $$0G:(DE-HGF)POF3-572$$a572 - (Dys-)function and Plasticity (POF3-572)$$cPOF3-572$$fPOF III$$x0
000850813 7001_ $$0P:(DE-Juel1)173675$$aKocher, M.$$b1
000850813 7001_ $$0P:(DE-HGF)0$$aSteger, J.$$b2
000850813 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, N.$$b3
000850813 773__ $$0PERI:(DE-600)2083933-9$$a10.23736/S1824-4785.18.03095-9$$n3$$p272-80$$tThe quarterly journal of nuclear medicine and molecular imaging$$v62$$x0392-0208$$y2018
000850813 8564_ $$uhttps://juser.fz-juelich.de/record/850813/files/Lohmann_Post%20Print_2018_Q%20J%20Nucl%20Med%20Mol%20Imaging_Radiomics%20derived%20from%20amino%20acid%20PET%20and%20conventional%20MRI%20in%20patients%20with%20high-grade%20gliomas.pdf$$yRestricted
000850813 8564_ $$uhttps://juser.fz-juelich.de/record/850813/files/R39Y2018N03A0272.pdf$$yRestricted
000850813 8564_ $$uhttps://juser.fz-juelich.de/record/850813/files/R39Y2018N03A0272.pdf?subformat=pdfa$$xpdfa$$yRestricted
000850813 8564_ $$uhttps://juser.fz-juelich.de/record/850813/files/Lohmann_Post%20Print_2018_Q%20J%20Nucl%20Med%20Mol%20Imaging_Radiomics%20derived%20from%20amino%20acid%20PET%20and%20conventional%20MRI%20in%20patients%20with%20high-grade%20gliomas.pdf?subformat=pdfa$$xpdfa$$yRestricted
000850813 909CO $$ooai:juser.fz-juelich.de:850813$$pVDB
000850813 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b0$$kFZJ
000850813 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173675$$aForschungszentrum Jülich$$b1$$kFZJ
000850813 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b3$$kFZJ
000850813 9131_ $$0G:(DE-HGF)POF3-572$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$v(Dys-)function and Plasticity$$x0
000850813 9141_ $$y2018
000850813 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000850813 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000850813 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000850813 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000850813 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000850813 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000850813 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000850813 920__ $$lyes
000850813 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000850813 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
000850813 980__ $$ajournal
000850813 980__ $$aVDB
000850813 980__ $$aI:(DE-Juel1)INM-3-20090406
000850813 980__ $$aI:(DE-Juel1)INM-4-20090406
000850813 980__ $$aUNRESTRICTED